Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasYuchen Jiao, Laura D. Wood, Aldo Scarpa et al.|Nature Genetics|2013Cited by 709
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors‐Pérez, Justo P. Castaño, Ricardo Blázquez‐Encinas et al.|Journal of Experimental & Clinical Cancer Research|2021Cited by 60
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors <scp>PRPF8</scp> and <scp>RBMX</scp> as novel candidate actionable targetsEmilia Alors‐Pérez, Justo P. Castaño, Ricardo Blázquez‐Encinas et al.|Molecular Oncology|2024Cited by 8
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinomaRicardo Blázquez‐Encinas, Justo P. Castaño, Emilia Alors‐Pérez et al.|Cancer Gene Therapy|2024Cited by 7
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors‐Pérez, Justo P. Castaño, Ricardo Blázquez‐Encinas et al.|Research Square|2021Cited by 2